Condition: Prostate Cancer (Diagnosis) · Sponsor: Guilin Medical University, China
The objective of the study is to construct a noninvasive approach ACP3 targeted PET/CT to detect tumor lesions in patients with prostate cancer and to compare with PSMA/FDG PET/CT.
This description comes directly from the study's public registry record.
Xingyu Mu, PhD · 86 13347631119 · muxingyu1992@hotmail.com
Wei Fu · 86 13977385850 · fuwei19700513@163.com
Always discuss trial participation with your own doctor first.
| The First Affliated Hospital of Guilin Medical University | Guilin, Guangxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07559201